Is a taper necessary for coming off semaglutide
We know for some, long-term use may be clinically appropriate
Paul Gao, Memorial Sloan Kettering Cancer Center, United States Can Hu, University of Chinese Academy of Sciences, China Updates Copyright 2023 Xu, Chen, Yu, Song, Jin and Gao
In adult clinical trials, 9.8% of patients treated with SAXENDA and 4.3% of patients treated with placebo prematurely discontinued treatment as a result of adverse reactions
What Is Semaglutide: Dive deeper into how this popular GLP-1 receptor agonist works
Understanding these interactions is important for providers in managing concurrent therapies and minimizing the risk of adverse effects